Prostate Biopsy and Mapping Augmented Reality Surgical Navigation  Bioprocessing Quality Control Endoluminal Robotics Academic Medical Center Enteral Feeding Intraoperative Molecular Imaging Medical Device Contract Manufacturing Clinical Research Organization

Robotic Surgery Hypoglycemia Sacroiliac Joint Pain Pharma Commercialization Services Academic Medical Center Clinical Research Organization Health Insurance TPA Medical Legal Regulatory (MLR) Consulting

This report provides a review of revenue performance of public companies in FSI’s Digital Health segments in 2022 as compared to previous years. Inside you will find FSI’s view of key trends from leading Digital Health companies and those investing in Digital Health (Medtech, the Big Four Tech, and Payors), as well as analysis of Digital Health VC investments, M&A, and IPOs

This report provides a review of revenue growth for public companies in FSI’s Medtech segments in H2 2022 as well as US Medtech investments and exits

Microbiome Consumables and Services Pulmonary Testing Clinical Research Organization Sleep Apnea Device Oncology CRO Pharma Clinical Trial Logistics Academic Medical Center Pharma Commercialization Services Digital Health Staffing Solution Clinical Research Organization Heath System Innovation Group Academic Medical Center Women's Health Novel Surgical Device Diligence Home Care Digital Health Solution

Key Digital Health trends and a spotlight on Surgery: The Intersection of Digital Health / AI and Medtech. Investments in Digital Health (Medtech, the Big Four Tech and Payers). Analysis of Digital Health VC investments, M&A and IPOs.

Chronic Limb Threatening Ischemia Pharma Commercialization Services Intraoperative Molecular Imaging Laparoscopic Surgery Smart Abdominal Binder Digital Health – Remote Patient Monitoring Protein Characterization Clinical Research Organization Senior Living

This report provides a review of revenue growth for public companies in FSI’s Life Science Tools and Diagnostics segments in 2022 as well as US investments and exits

This report highlights FSI's Peripheral Vascular (PV) Device Review. Inside you will find the following: - Revenue performance of key public companies, as well as peripheral vascular M&A and investments through 2022 - FSI’s view of key trends from leading companies in the PV space and those investing in peripheral vascular - devices - Analysis of VC investments in select PV device segments, as well as M&A activity and IPOs

This report highlights FSI's Cardiovascular Device Review of 2022. Inside you will find the following: - Revenue performance of key public companies, as well as cardiovascular M&A and investments through 2022  - FSI’s view of key trends from leading cardiovascular device companies and those investing in cardiovascular devices   - Analysis of VC investments in select cardiovascular device segments, as well as M&A activity and IPOs